Add listing
    0
    Add listing

    ADX71149 (mGlu2 PAM) for Epilepsy

    Indicaton

    Epilepsy

    Milestone: H2 2023

    ADX71149 for the treatment of epilepsy.

    ADX71149 is a selective metabotropic glutamate sub-type 2 (mGlu2) receptor positive allosteric modulator (PAM).

    Therapeutic indications
    Type of product
    Table
    • Phase
      Phase II started
    • Partnering status
      Partnered
    • Partner
      Janssen Pharmaceutica

    You may also be interested in